Haleon (NYSE:HLN) Sees Strong Trading Volume - Here's Why

Haleon plc (NYSE:HLN - Get Free Report) saw unusually-high trading volume on Friday . Approximately 14,932,207 shares changed hands during trading, an increase of 77% from the previous session's volume of 8,428,322 shares.The stock last traded at $11.32 and had previously closed at $11.33.

Analyst Upgrades and Downgrades

HLN has been the subject of several research reports. BNP Paribas raised shares of Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 5th. Barclays reissued an "overweight" rating on shares of Haleon in a research note on Tuesday, May 6th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a research note on Monday, March 3rd. Finally, Wall Street Zen cut shares of Haleon from a "buy" rating to a "hold" rating in a research note on Thursday, May 22nd. Six equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $12.33.

Haleon Trading Up 0.3%

The business's 50-day moving average is $10.40 and its two-hundred day moving average is $9.98. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $51.17 billion, a PE ratio of 33.41, a PEG ratio of 2.82 and a beta of 0.24.

Haleon (NYSE:HLN - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The firm had revenue of $3.54 billion during the quarter, compared to analysts' expectations of $3.38 billion. On average, analysts predict that Haleon plc will post 0.43 earnings per share for the current year.

Hedge Funds Weigh In On Haleon

A number of institutional investors have recently added to or reduced their stakes in the company. Sierra Ocean LLC purchased a new position in Haleon in the 4th quarter valued at about $26,000. Bartlett & CO. Wealth Management LLC boosted its position in Haleon by 135.9% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after buying an additional 1,491 shares during the last quarter. Banque Transatlantique SA purchased a new position in Haleon in the 1st quarter valued at about $27,000. Opal Wealth Advisors LLC purchased a new position in Haleon in the 1st quarter valued at about $29,000. Finally, Ransom Advisory Ltd purchased a new position in Haleon in the 1st quarter valued at about $31,000. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.